DrugCard

AI-driven tool streamlines multilingual pharmacovigilance literature screening.

What is DrugCard? DrugCard supports pharmacovigilance, offering AI-driven solutions for local literature screening. Designed for Contract Research Organizations (CROs), Marketing Authorization Holders (MAHs), and freelancers, it simplifies the complex task of monitoring drug safety across multiple regions and languages. Key Features: AI-Enabled Data Intelligence: Utilizes advanced AI algorithms to streamline pharmacovigilance processes, ensuring comprehensive drug safety monitoring. Multi-Language Support: Capable of screening medical literature in over 100 languages, making it a versatile tool for global use. OCR Technology: Proprietary OCR technology delivers up to 99% accuracy, even with poorly scanned texts, ensuring reliable data extraction. Scalable and Flexible: Easily adapts to new markets and integrates additional journals within 2-3 weeks, supporting multi-region operations. Pros Time Efficiency: Users report a 50-70% reduction in time spent on literature screening compared to manual methods. High Accuracy: Achieves 99% accuracy in keyword recognition, minimizing errors in data collection. Cost-Effective: Eliminates the need for heavy CAPEX investments, offering a budget-friendly solution for pharmacovigilance. Improved Compliance: Provides traceable and transparent processes, aiding in regulatory compliance and reducing audit risks.